Pricing Log in Create free account

Vyome Holdings, Inc. (HIND) vs Passage Bio, Inc. (PASG)

Vyome Holdings, Inc. and Passage Bio, Inc. are both Biotechnology companies. Vyome Holdings, Inc. and Passage Bio, Inc. are of similar size ($11.4M and $11.1M). Passage Bio, Inc. has the higher net margin (0.00% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Vyome Holdings, Inc. leads on 7 and Passage Bio, Inc. on 5.

Valuation

Metric HIND PASG Biotechnology median
P/E n/m n/m 10.60
P/S 86.52 n/m 9.40
P/B 1.54 2.81 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.30 0.66
EV/Sales 124.04 n/m 9.02
Earnings yield (223.64%) (290.26%) (32.88%)
Free cash flow yield (49.67%) (291.49%) (23.13%)

Profitability

Metric HIND PASG Biotechnology median
Gross margin 52.77% 0.00% 68.51%
Operating margin (9,184.82%) 0.00% 0.00%
Net margin (8,711.71%) 0.00% 0.00%
Free cash flow margin (4,298.00%) 0.00% 0.00%
Return on equity (172.10%) (169.09%) (51.96%)
Return on assets (124.23%) (69.20%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HIND PASG Biotechnology median
Revenue growth (TTM) (67.10%) — 6.76%
EPS growth (last fiscal year) 99.92% 32.94% 29.88%
Revenue growth, 5-year CAGR (50.98%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HIND PASG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.37 1.22 4.97
Net debt to EBITDA 0.48 0.96 1.01

Dividend

Metric HIND PASG Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HIND PASG Biotechnology median
Market cap 11.44m 11.13m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack